nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—BCHE—diaphragm—liver cancer	0.0449	0.482	CbGeAlD
Perindopril—ACE—umbilical vein—liver cancer	0.0272	0.292	CbGeAlD
Perindopril—ACE—embryo—liver cancer	0.0071	0.0762	CbGeAlD
Perindopril—SLC15A1—liver—liver cancer	0.00458	0.0492	CbGeAlD
Perindopril—ACE—liver—liver cancer	0.00329	0.0353	CbGeAlD
Perindopril—ABCB1—embryo—liver cancer	0.0025	0.0268	CbGeAlD
Perindopril—BCHE—liver—liver cancer	0.00243	0.026	CbGeAlD
Perindopril—Renal impairment—Doxorubicin—liver cancer	0.00189	0.00209	CcSEcCtD
Perindopril—Face oedema—Epirubicin—liver cancer	0.00188	0.00207	CcSEcCtD
Perindopril—Purpura—Doxorubicin—liver cancer	0.00187	0.00206	CcSEcCtD
Perindopril—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00186	0.00205	CcSEcCtD
Perindopril—Asthenia—Sorafenib—liver cancer	0.00186	0.00205	CcSEcCtD
Perindopril—Cardiac arrest—Epirubicin—liver cancer	0.00185	0.00204	CcSEcCtD
Perindopril—Mood swings—Epirubicin—liver cancer	0.00184	0.00203	CcSEcCtD
Perindopril—Cerebrovascular accident—Doxorubicin—liver cancer	0.00184	0.00203	CcSEcCtD
Perindopril—Pruritus—Sorafenib—liver cancer	0.00183	0.00202	CcSEcCtD
Perindopril—Blood creatinine increased—Epirubicin—liver cancer	0.00182	0.00201	CcSEcCtD
Perindopril—Hyponatraemia—Doxorubicin—liver cancer	0.00181	0.00199	CcSEcCtD
Perindopril—Pain in extremity—Doxorubicin—liver cancer	0.0018	0.00199	CcSEcCtD
Perindopril—Dry skin—Epirubicin—liver cancer	0.00178	0.00197	CcSEcCtD
Perindopril—Orthostatic hypotension—Epirubicin—liver cancer	0.00178	0.00196	CcSEcCtD
Perindopril—Abdominal pain upper—Epirubicin—liver cancer	0.00178	0.00196	CcSEcCtD
Perindopril—Migraine—Doxorubicin—liver cancer	0.00177	0.00196	CcSEcCtD
Perindopril—Diarrhoea—Sorafenib—liver cancer	0.00177	0.00195	CcSEcCtD
Perindopril—Breast disorder—Epirubicin—liver cancer	0.00176	0.00194	CcSEcCtD
Perindopril—Nasopharyngitis—Epirubicin—liver cancer	0.00174	0.00192	CcSEcCtD
Perindopril—Face oedema—Doxorubicin—liver cancer	0.00174	0.00192	CcSEcCtD
Perindopril—Muscular weakness—Epirubicin—liver cancer	0.00172	0.00189	CcSEcCtD
Perindopril—Cardiac arrest—Doxorubicin—liver cancer	0.00171	0.00189	CcSEcCtD
Perindopril—Dizziness—Sorafenib—liver cancer	0.00171	0.00189	CcSEcCtD
Perindopril—Mood swings—Doxorubicin—liver cancer	0.00171	0.00188	CcSEcCtD
Perindopril—Blood creatinine increased—Doxorubicin—liver cancer	0.00169	0.00186	CcSEcCtD
Perindopril—Asthma—Epirubicin—liver cancer	0.00168	0.00186	CcSEcCtD
Perindopril—Eosinophilia—Epirubicin—liver cancer	0.00167	0.00184	CcSEcCtD
Perindopril—Dry skin—Doxorubicin—liver cancer	0.00165	0.00182	CcSEcCtD
Perindopril—Pancreatitis—Epirubicin—liver cancer	0.00165	0.00182	CcSEcCtD
Perindopril—Vomiting—Sorafenib—liver cancer	0.00165	0.00182	CcSEcCtD
Perindopril—Abdominal pain upper—Doxorubicin—liver cancer	0.00165	0.00181	CcSEcCtD
Perindopril—Orthostatic hypotension—Doxorubicin—liver cancer	0.00165	0.00181	CcSEcCtD
Perindopril—Angina pectoris—Epirubicin—liver cancer	0.00164	0.00181	CcSEcCtD
Perindopril—Rash—Sorafenib—liver cancer	0.00163	0.0018	CcSEcCtD
Perindopril—Dermatitis—Sorafenib—liver cancer	0.00163	0.0018	CcSEcCtD
Perindopril—Breast disorder—Doxorubicin—liver cancer	0.00163	0.0018	CcSEcCtD
Perindopril—Headache—Sorafenib—liver cancer	0.00162	0.00179	CcSEcCtD
Perindopril—Bronchitis—Epirubicin—liver cancer	0.00162	0.00178	CcSEcCtD
Perindopril—Nasopharyngitis—Doxorubicin—liver cancer	0.00161	0.00178	CcSEcCtD
Perindopril—Pancytopenia—Epirubicin—liver cancer	0.0016	0.00176	CcSEcCtD
Perindopril—Muscular weakness—Doxorubicin—liver cancer	0.00159	0.00175	CcSEcCtD
Perindopril—Neutropenia—Epirubicin—liver cancer	0.00157	0.00174	CcSEcCtD
Perindopril—Upper respiratory tract infection—Epirubicin—liver cancer	0.00156	0.00172	CcSEcCtD
Perindopril—Asthma—Doxorubicin—liver cancer	0.00156	0.00172	CcSEcCtD
Perindopril—Pollakiuria—Epirubicin—liver cancer	0.00155	0.00171	CcSEcCtD
Perindopril—Eosinophilia—Doxorubicin—liver cancer	0.00154	0.0017	CcSEcCtD
Perindopril—Nausea—Sorafenib—liver cancer	0.00154	0.0017	CcSEcCtD
Perindopril—Photosensitivity reaction—Epirubicin—liver cancer	0.00154	0.00169	CcSEcCtD
Perindopril—Pancreatitis—Doxorubicin—liver cancer	0.00153	0.00168	CcSEcCtD
Perindopril—Angina pectoris—Doxorubicin—liver cancer	0.00152	0.00167	CcSEcCtD
Perindopril—Pneumonia—Epirubicin—liver cancer	0.00151	0.00166	CcSEcCtD
Perindopril—Drowsiness—Epirubicin—liver cancer	0.0015	0.00165	CcSEcCtD
Perindopril—Bronchitis—Doxorubicin—liver cancer	0.0015	0.00165	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.00149	0.00164	CcSEcCtD
Perindopril—Pancytopenia—Doxorubicin—liver cancer	0.00148	0.00163	CcSEcCtD
Perindopril—Renal failure—Epirubicin—liver cancer	0.00147	0.00163	CcSEcCtD
Perindopril—Jaundice—Epirubicin—liver cancer	0.00146	0.00161	CcSEcCtD
Perindopril—Stomatitis—Epirubicin—liver cancer	0.00146	0.00161	CcSEcCtD
Perindopril—Urinary tract infection—Epirubicin—liver cancer	0.00146	0.00161	CcSEcCtD
Perindopril—Conjunctivitis—Epirubicin—liver cancer	0.00146	0.00161	CcSEcCtD
Perindopril—Neutropenia—Doxorubicin—liver cancer	0.00146	0.00161	CcSEcCtD
Perindopril—Upper respiratory tract infection—Doxorubicin—liver cancer	0.00145	0.0016	CcSEcCtD
Perindopril—Sweating—Epirubicin—liver cancer	0.00144	0.00159	CcSEcCtD
Perindopril—Pollakiuria—Doxorubicin—liver cancer	0.00144	0.00159	CcSEcCtD
Perindopril—Haematuria—Epirubicin—liver cancer	0.00143	0.00158	CcSEcCtD
Perindopril—Photosensitivity reaction—Doxorubicin—liver cancer	0.00142	0.00157	CcSEcCtD
Perindopril—Hepatobiliary disease—Epirubicin—liver cancer	0.00142	0.00156	CcSEcCtD
Perindopril—Epistaxis—Epirubicin—liver cancer	0.00142	0.00156	CcSEcCtD
Perindopril—Sinusitis—Epirubicin—liver cancer	0.00141	0.00155	CcSEcCtD
Perindopril—Agranulocytosis—Epirubicin—liver cancer	0.0014	0.00154	CcSEcCtD
Perindopril—Pneumonia—Doxorubicin—liver cancer	0.0014	0.00154	CcSEcCtD
Perindopril—Drowsiness—Doxorubicin—liver cancer	0.00139	0.00153	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.00138	0.00152	CcSEcCtD
Perindopril—Bradycardia—Epirubicin—liver cancer	0.00137	0.00151	CcSEcCtD
Perindopril—Renal failure—Doxorubicin—liver cancer	0.00136	0.0015	CcSEcCtD
Perindopril—Haemoglobin—Epirubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Jaundice—Doxorubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Stomatitis—Doxorubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Rhinitis—Epirubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Conjunctivitis—Doxorubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Urinary tract infection—Doxorubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Haemorrhage—Epirubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Hepatitis—Epirubicin—liver cancer	0.00135	0.00149	CcSEcCtD
Perindopril—Pharyngitis—Epirubicin—liver cancer	0.00134	0.00147	CcSEcCtD
Perindopril—Sweating—Doxorubicin—liver cancer	0.00133	0.00147	CcSEcCtD
Perindopril—Urinary tract disorder—Epirubicin—liver cancer	0.00133	0.00147	CcSEcCtD
Perindopril—Oedema peripheral—Epirubicin—liver cancer	0.00133	0.00146	CcSEcCtD
Perindopril—Haematuria—Doxorubicin—liver cancer	0.00132	0.00146	CcSEcCtD
Perindopril—Urethral disorder—Epirubicin—liver cancer	0.00132	0.00146	CcSEcCtD
Perindopril—Hepatobiliary disease—Doxorubicin—liver cancer	0.00131	0.00145	CcSEcCtD
Perindopril—Epistaxis—Doxorubicin—liver cancer	0.00131	0.00144	CcSEcCtD
Perindopril—Sinusitis—Doxorubicin—liver cancer	0.0013	0.00144	CcSEcCtD
Perindopril—Visual impairment—Epirubicin—liver cancer	0.0013	0.00143	CcSEcCtD
Perindopril—Agranulocytosis—Doxorubicin—liver cancer	0.0013	0.00143	CcSEcCtD
Perindopril—Erythema multiforme—Epirubicin—liver cancer	0.00127	0.0014	CcSEcCtD
Perindopril—Bradycardia—Doxorubicin—liver cancer	0.00127	0.0014	CcSEcCtD
Perindopril—Eye disorder—Epirubicin—liver cancer	0.00126	0.00139	CcSEcCtD
Perindopril—Tinnitus—Epirubicin—liver cancer	0.00126	0.00138	CcSEcCtD
Perindopril—Haemoglobin—Doxorubicin—liver cancer	0.00125	0.00138	CcSEcCtD
Perindopril—Flushing—Epirubicin—liver cancer	0.00125	0.00138	CcSEcCtD
Perindopril—Cardiac disorder—Epirubicin—liver cancer	0.00125	0.00138	CcSEcCtD
Perindopril—Rhinitis—Doxorubicin—liver cancer	0.00125	0.00138	CcSEcCtD
Perindopril—Hepatitis—Doxorubicin—liver cancer	0.00125	0.00137	CcSEcCtD
Perindopril—Haemorrhage—Doxorubicin—liver cancer	0.00125	0.00137	CcSEcCtD
Perindopril—Pharyngitis—Doxorubicin—liver cancer	0.00124	0.00136	CcSEcCtD
Perindopril—Urinary tract disorder—Doxorubicin—liver cancer	0.00123	0.00136	CcSEcCtD
Perindopril—Oedema peripheral—Doxorubicin—liver cancer	0.00123	0.00135	CcSEcCtD
Perindopril—Angiopathy—Epirubicin—liver cancer	0.00122	0.00135	CcSEcCtD
Perindopril—Urethral disorder—Doxorubicin—liver cancer	0.00122	0.00135	CcSEcCtD
Perindopril—Mediastinal disorder—Epirubicin—liver cancer	0.00121	0.00134	CcSEcCtD
Perindopril—Chills—Epirubicin—liver cancer	0.00121	0.00133	CcSEcCtD
Perindopril—Arrhythmia—Epirubicin—liver cancer	0.0012	0.00133	CcSEcCtD
Perindopril—Visual impairment—Doxorubicin—liver cancer	0.0012	0.00132	CcSEcCtD
Perindopril—Alopecia—Epirubicin—liver cancer	0.00119	0.00131	CcSEcCtD
Perindopril—Mental disorder—Epirubicin—liver cancer	0.00118	0.0013	CcSEcCtD
Perindopril—Erythema multiforme—Doxorubicin—liver cancer	0.00118	0.0013	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—liver cancer	0.00117	0.00129	CcSEcCtD
Perindopril—Erythema—Epirubicin—liver cancer	0.00117	0.00129	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—liver cancer	0.00116	0.00128	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—liver cancer	0.00116	0.00128	CcSEcCtD
Perindopril—Flushing—Doxorubicin—liver cancer	0.00116	0.00128	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—liver cancer	0.00116	0.00128	CcSEcCtD
Perindopril—ABCB1—liver—liver cancer	0.00116	0.0124	CbGeAlD
Perindopril—Flatulence—Epirubicin—liver cancer	0.00116	0.00127	CcSEcCtD
Perindopril—Tension—Epirubicin—liver cancer	0.00115	0.00127	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—liver cancer	0.00115	0.00127	CcSEcCtD
Perindopril—Nervousness—Epirubicin—liver cancer	0.00114	0.00126	CcSEcCtD
Perindopril—Back pain—Epirubicin—liver cancer	0.00113	0.00125	CcSEcCtD
Perindopril—Angiopathy—Doxorubicin—liver cancer	0.00113	0.00125	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—liver cancer	0.00113	0.00124	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—liver cancer	0.00112	0.00124	CcSEcCtD
Perindopril—Chills—Doxorubicin—liver cancer	0.00112	0.00123	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—liver cancer	0.00111	0.00123	CcSEcCtD
Perindopril—Alopecia—Doxorubicin—liver cancer	0.0011	0.00121	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—liver cancer	0.00109	0.0012	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—liver cancer	0.00109	0.0012	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—liver cancer	0.00108	0.0012	CcSEcCtD
Perindopril—Erythema—Doxorubicin—liver cancer	0.00108	0.0012	CcSEcCtD
Perindopril—Anaemia—Epirubicin—liver cancer	0.00108	0.0012	CcSEcCtD
Perindopril—Agitation—Epirubicin—liver cancer	0.00108	0.00119	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—liver cancer	0.00107	0.00118	CcSEcCtD
Perindopril—Tension—Doxorubicin—liver cancer	0.00106	0.00117	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—liver cancer	0.00106	0.00117	CcSEcCtD
Perindopril—Malaise—Epirubicin—liver cancer	0.00106	0.00117	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—liver cancer	0.00105	0.00116	CcSEcCtD
Perindopril—Vertigo—Epirubicin—liver cancer	0.00105	0.00116	CcSEcCtD
Perindopril—Syncope—Epirubicin—liver cancer	0.00105	0.00116	CcSEcCtD
Perindopril—Leukopenia—Epirubicin—liver cancer	0.00105	0.00116	CcSEcCtD
Perindopril—Back pain—Doxorubicin—liver cancer	0.00105	0.00116	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—liver cancer	0.00104	0.00115	CcSEcCtD
Perindopril—Palpitations—Epirubicin—liver cancer	0.00104	0.00114	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—liver cancer	0.00103	0.00114	CcSEcCtD
Perindopril—Cough—Epirubicin—liver cancer	0.00102	0.00113	CcSEcCtD
Perindopril—Hypertension—Epirubicin—liver cancer	0.00101	0.00112	CcSEcCtD
Perindopril—Ill-defined disorder—Doxorubicin—liver cancer	0.00101	0.00111	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—liver cancer	0.001	0.00111	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—liver cancer	0.000998	0.0011	CcSEcCtD
Perindopril—Myalgia—Epirubicin—liver cancer	0.000998	0.0011	CcSEcCtD
Perindopril—Chest pain—Epirubicin—liver cancer	0.000998	0.0011	CcSEcCtD
Perindopril—Agitation—Doxorubicin—liver cancer	0.000997	0.0011	CcSEcCtD
Perindopril—Anxiety—Epirubicin—liver cancer	0.000995	0.0011	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000991	0.00109	CcSEcCtD
Perindopril—Discomfort—Epirubicin—liver cancer	0.000986	0.00109	CcSEcCtD
Perindopril—Malaise—Doxorubicin—liver cancer	0.000978	0.00108	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—liver cancer	0.000976	0.00108	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—liver cancer	0.000975	0.00107	CcSEcCtD
Perindopril—Syncope—Doxorubicin—liver cancer	0.000973	0.00107	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—liver cancer	0.000971	0.00107	CcSEcCtD
Perindopril—Confusional state—Epirubicin—liver cancer	0.000965	0.00106	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—liver cancer	0.000959	0.00106	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—liver cancer	0.000957	0.00106	CcSEcCtD
Perindopril—Oedema—Epirubicin—liver cancer	0.000957	0.00106	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—liver cancer	0.000953	0.00105	CcSEcCtD
Perindopril—Cough—Doxorubicin—liver cancer	0.000947	0.00104	CcSEcCtD
Perindopril—Shock—Epirubicin—liver cancer	0.000941	0.00104	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—liver cancer	0.000938	0.00103	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—liver cancer	0.000937	0.00103	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—liver cancer	0.000937	0.00103	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—liver cancer	0.000934	0.00103	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—liver cancer	0.000929	0.00102	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—liver cancer	0.000925	0.00102	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—liver cancer	0.000924	0.00102	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—liver cancer	0.000924	0.00102	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—liver cancer	0.000924	0.00102	CcSEcCtD
Perindopril—Anxiety—Doxorubicin—liver cancer	0.00092	0.00101	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000917	0.00101	CcSEcCtD
Perindopril—Discomfort—Doxorubicin—liver cancer	0.000913	0.00101	CcSEcCtD
Perindopril—Anorexia—Epirubicin—liver cancer	0.000912	0.00101	CcSEcCtD
Perindopril—Dry mouth—Doxorubicin—liver cancer	0.000903	0.000996	CcSEcCtD
Perindopril—Hypotension—Epirubicin—liver cancer	0.000894	0.000986	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—liver cancer	0.000893	0.000984	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—liver cancer	0.000885	0.000976	CcSEcCtD
Perindopril—Oedema—Doxorubicin—liver cancer	0.000885	0.000976	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000872	0.000961	CcSEcCtD
Perindopril—Shock—Doxorubicin—liver cancer	0.000871	0.000961	CcSEcCtD
Perindopril—Nervous system disorder—Doxorubicin—liver cancer	0.000868	0.000957	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—liver cancer	0.000867	0.000956	CcSEcCtD
Perindopril—Insomnia—Epirubicin—liver cancer	0.000865	0.000954	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—liver cancer	0.000864	0.000953	CcSEcCtD
Perindopril—Skin disorder—Doxorubicin—liver cancer	0.00086	0.000948	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—liver cancer	0.000859	0.000948	CcSEcCtD
Perindopril—Hyperhidrosis—Doxorubicin—liver cancer	0.000856	0.000944	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—liver cancer	0.000853	0.000941	CcSEcCtD
Perindopril—Somnolence—Epirubicin—liver cancer	0.000851	0.000938	CcSEcCtD
Perindopril—Anorexia—Doxorubicin—liver cancer	0.000844	0.000931	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—liver cancer	0.000842	0.000929	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—liver cancer	0.000832	0.000917	CcSEcCtD
Perindopril—Hypotension—Doxorubicin—liver cancer	0.000827	0.000912	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—liver cancer	0.000826	0.000911	CcSEcCtD
Perindopril—Fatigue—Epirubicin—liver cancer	0.000825	0.00091	CcSEcCtD
Perindopril—Pain—Epirubicin—liver cancer	0.000818	0.000902	CcSEcCtD
Perindopril—Constipation—Epirubicin—liver cancer	0.000818	0.000902	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000807	0.00089	CcSEcCtD
Perindopril—Insomnia—Doxorubicin—liver cancer	0.000801	0.000883	CcSEcCtD
Perindopril—Paraesthesia—Doxorubicin—liver cancer	0.000795	0.000877	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—liver cancer	0.000789	0.00087	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—liver cancer	0.000789	0.00087	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—liver cancer	0.000787	0.000868	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—liver cancer	0.000782	0.000863	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—liver cancer	0.000779	0.000859	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—liver cancer	0.00077	0.000849	CcSEcCtD
Perindopril—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000764	0.000843	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—liver cancer	0.000763	0.000842	CcSEcCtD
Perindopril—Urticaria—Epirubicin—liver cancer	0.00076	0.000838	CcSEcCtD
Perindopril—Constipation—Doxorubicin—liver cancer	0.000757	0.000835	CcSEcCtD
Perindopril—Pain—Doxorubicin—liver cancer	0.000757	0.000835	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—liver cancer	0.000756	0.000834	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—liver cancer	0.000756	0.000834	CcSEcCtD
Perindopril—Feeling abnormal—Doxorubicin—liver cancer	0.00073	0.000805	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—liver cancer	0.000724	0.000798	CcSEcCtD
Perindopril—Urticaria—Doxorubicin—liver cancer	0.000703	0.000776	CcSEcCtD
Perindopril—Abdominal pain—Doxorubicin—liver cancer	0.0007	0.000772	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—liver cancer	0.0007	0.000772	CcSEcCtD
Perindopril—Asthenia—Epirubicin—liver cancer	0.000687	0.000757	CcSEcCtD
Perindopril—Pruritus—Epirubicin—liver cancer	0.000677	0.000747	CcSEcCtD
Perindopril—Diarrhoea—Epirubicin—liver cancer	0.000655	0.000722	CcSEcCtD
Perindopril—Asthenia—Doxorubicin—liver cancer	0.000635	0.000701	CcSEcCtD
Perindopril—Dizziness—Epirubicin—liver cancer	0.000633	0.000698	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—liver cancer	0.000626	0.000691	CcSEcCtD
Perindopril—Vomiting—Epirubicin—liver cancer	0.000608	0.000671	CcSEcCtD
Perindopril—Diarrhoea—Doxorubicin—liver cancer	0.000606	0.000668	CcSEcCtD
Perindopril—Rash—Epirubicin—liver cancer	0.000603	0.000665	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—liver cancer	0.000603	0.000665	CcSEcCtD
Perindopril—Headache—Epirubicin—liver cancer	0.000599	0.000661	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—liver cancer	0.000585	0.000646	CcSEcCtD
Perindopril—Nausea—Epirubicin—liver cancer	0.000568	0.000627	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—liver cancer	0.000563	0.000621	CcSEcCtD
Perindopril—Rash—Doxorubicin—liver cancer	0.000558	0.000616	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—liver cancer	0.000558	0.000615	CcSEcCtD
Perindopril—Headache—Doxorubicin—liver cancer	0.000555	0.000612	CcSEcCtD
Perindopril—Nausea—Doxorubicin—liver cancer	0.000526	0.00058	CcSEcCtD
